DIHYDROQUERCETIN: PHARMACOLOGICAL PROPERTIES, POSSIBILITY OF USING THE DRUG IN CLINICAL PRACTICE

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper presented a scientific review of 19 publications by authors from the Netherlands, the Russian Federation, Great Britain, China, India, South Korea, the United States, Egypt, and Slovakia. We studied: the pharmacological properties of dihydroquercetin. Reflected the antioxidant, anti-inflammatory, antimicrobial, antitumor effects of Dihydroquercetin on the human body. Shown the prospects of using dihydroquercetine in clinical practice: in patients with cardiovascular diseases, with diabetes, in oncology, neurology, surgery, in COVID-19

Full Text

Restricted Access

About the authors

D. V Dedov

Tver State Medical University; Tver Regional Clinical Cardiology Dispensary

Author for correspondence.
Email: dedov_d@inbox.ru

Professor, MD

Russian Federation,

References

  1. Turck D., Bresson J.-L., Burlingame B. et al. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on taxifolin-rich extract from Dahurian Larch (Larix gmelinii). EFSA Journal. 2017; 15 (2): 4682. DOI: 10.2903/j. efsa.2017.4682
  2. Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008; 585 (2-3): 325-37. doi: 10.1016/j.ejphar.2008.03.008
  3. Терехов Р.П. Влияние фазового состояния на физико-химические, технологические и биофармацевтические параметры дигидрокверцетина. Дисс.. канд. мед. наук. М., 2021; 173 с.
  4. Taldaev A., Terekhov R., Nikitin I. et al. Insights into the Pharmacological Effects of Flavonoids: The Systematic Review of Computer Modeling.Int J Mol Sci. 2022; 23 (11): 6023. doi: 10.3390/ijms23116023
  5. Weidmann A.E. Dihydroquercetin: More than just an impurity? Eur J Pharmacol. 2012; 684 (1-3): 19-26. doi: 10.1016/j.ejphar.2012.03.035
  6. Ковалевская Е.Г. Оптимизация условий производства субстанции дигидрокверцетина, разработка лекарственного препарата на ее основе. Автореф. дисс. канд. мед. наук. Пятигорск, 2014; 24 с.
  7. Sunil C., Xu B. An insight into the health-promoting effects of taxifolin (dihydroquercetin). Phytochemistry. 2019; 166: 112066. doi: 10.1016/j.phytochem.2019.112066
  8. Alam Q., Krishnamurthy S. Dihydroquercetin ameliorates LPS-induced neuroinflammation and memory deficit. Curr Res Pharmacol Drug Discov. 2022; 3: 100091. DOI: 10.1016/j. crphar.2022.100091
  9. Islam J., Shree A., Vafa A. et al. Taxifolin ameliorates Benzo[a]pyrene-induced lung injury possibly via stimulating the Nrf2 signalling pathway.Int Immunopharmacol. 2021; 96: 107566. doi: 10.1016/j.intimp.2021.107566
  10. Jiang W., Wei H., He B. Dietary flavonoids intake and the risk of coronary heart disease: a dose-response meta-analysis of 15 prospective studies. Thromb Res. 2015; 135 (3): 459-63. doi: 10.1016/j.thromres.2014.12.016
  11. Kim Y., Je Y. Flavonoid intake and mortality from cardiovascular disease and all causes: A meta-analysis of prospective cohort studies. Clin Nutr ESPEN. 2017; 20: 68-77. doi: 10.1016/j.clnesp.2017.03.004
  12. Liu Y.J., Zhan J., Liu X.L. et al. Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Clin Nutr. 2014; 33 (1): 59-63. DOI: 10.1016/j. clnu.2013.03.011
  13. Das A., Baidya R., Chakraborty T. et al. Pharmacological basis and new insights of taxifolin: A comprehensive review. Biomed Pharmacother. 2021; 142: 112004. DOI: 10.1016/j. biopha.2021.112004
  14. Chang S.C., Cassidy A., Willett W.C. et al. Dietary flavonoid intake and risk of incident depression in midlife and older women. Am J Clin Nutr. 2016; 104 (3): 704-14. DOI: 10.3945/ ajcn.115.124545
  15. Zhu Y., Scholle F., Kisthardt S.C. et al. Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E. Virology. 2022; 571: 21-33. doi: 10.1016/j.virol.2022.04.005
  16. Щукина О.Г. Экспериментальное исследование ранозаживляющих свойств дигидрокверцетина при термической травме кожи. Автореф. дисс.. канд. биол. наук. СПб, 2013; 28 с.
  17. Hassan M.A., Tamer T.M., Valachova K. et al. Antioxidant and antibacterial polyelectrolyte wound dressing based on chitosan/hyaluronan/phosphatidylcholine dihydroquercetin.Int J Biol Macromol. 2021; 166: 18-31. DOI: 10.1016/j. ijbiomac.2020.11.119
  18. Zhang J., Chen K., Ding C. et al. Fabrication of chitosan/PVP/dihydroquercetin nanocomposite film for in vitro and in vivo evaluation of wound healing.Int J Biol Macromol. 2022; 206: 591-604. doi: 10.1016/j.ijbiomac.2022.02.110
  19. Тюкавкина Н.А., Руленко И.А., Колесник Ю.А. Дигидрокверцетин - новая антиоксидантная и биологически активная пищевая добавка. Вопросы питания. 1997; 6: 12-5.
  20. Плотников М.Б., Логвинов С.В., Пугаченко Н.В. и др. Церебропротекторные эффекты смеси диквертина и аскорбиновой кислоты. Фармакология и токсикология. 2000; 130 (11): 543-7.
  21. Плотников М.Б., Тюкавкина Н.А., Алиев О.И. и др. Клиническая эффективность нового гемореологического препарата «Асковертин» у больных с дисциркуляторной энцефалопатией. Журнал неврологии и психиатрии им. С.С. Корсакова. 2004; 12: 33-7.
  22. Доровских В.А., Целуйко С.С., Симонова Н.В. и др. В мире антиоксидантов: учебное пособие. Благовещенск: Амурская государственная медицинская академия, 2012; 106 с.
  23. Бабкин В.А., Остроухова Л.А., Левчук А.А. и др. Влияние условий экстракции на выход нативного дигидрокверцетина, содержащего более 97% (+)-транс-изомера. Химико-фармацевтический журнал. 2017; 51 (1): 39-41.
  24. Xu Q., Parks C.G., DeRoo L.A. et al. Multivitamin use and telomere length in women. Am J Clin Nutr. 2009; 89 (6): 1857-63. doi: 10.3945/ajcn.2008.26986

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2022 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies